中文 | English
Return
Total: 56 , 1/6
Show Home Prev Next End page: GO
Author:(Lü-Nan YAN)

2.Current status and prospect of liver transplantation for hepatocellular carcinoma.

Lü-Nan YAN

Acta Academiae Medicinae Sinicae 2005;27(4):427-430

4.Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo.

Dong XIA ; Liang XU ; Hua FU ; Xiao-Long QI ; Yi QUAN ; Lü-Nan YAN

Chinese Journal of Oncology 2007;29(11):813-817

5.Feasibility of small size graft following living donor liver transplantation.

Xiang LAN ; Bo LI ; Xiao-fei WANG ; Ci-jun PENG ; Yong-gang WEI ; Lü-nan YAN

Chinese Journal of Surgery 2009;47(16):1218-1220

7.Combined indocyanine green test and standard remnant liver volume to predict post-hepatectomy hepatic insufficiency for the patients with hepatocellular carcinoma.

Zheng-gui DU ; Bo LI ; Xi FENG ; Jie YIN ; Lü-nan YAN ; Tian-fu WEN ; Yong ZENG

Chinese Journal of Surgery 2010;48(3):189-192

9.Modified ( narrowed ) gastric tube and establishment of enteral feeding pathway in surgery of esophageal carcinoma (esophagectomy)

Yuan FENG ; Nan WU ; Shi YAN ; Jinfeng CHEN ; Qingfeng ZHENG ; Chao Lü ; Yuzhao WANG ; Shaolei LI ; Lijian ZHANG ; Jiafu JI ; Yue YANG

Chinese Journal of Clinical Nutrition 2011;19(6):377-382

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 56 , 1/6 Show Home Prev Next End page: GO